Keros Therapeutics Net Tangible Assets

Keros Therapeutics (KROS) currently reports a net tangible assets of $260M as of June 2026. That compares with $710M in the prior-year period — down 62.9% year over year. Use the charts on this page to explore Keros Therapeutics's net tangible assets history and peer comparisons.

Keros Therapeutics's net tangible assets decreased from $710M to $260M — a 62.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Keros Therapeutics reported $260M in net tangible assets as of June 2026. That compares with $710M in the prior-year period — down 62.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $260M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Keros Therapeutics, and consider following KROS for alerts when major investors trade the stock.

Keros Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $260M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KROS with unrelated industries.